AI assistant
Sending…
Ascletis Pharma Inc. — Earnings Release 2002
Sep 9, 2002
50081_rns_2002-09-09_d9edc182-a118-4740-9ea6-8d6f820bb123.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| WORLD HOUSEWARE<00713> - Results Announcement (Summary) World Houseware (Holdings) Limited announced on 9/9/2002: (stock code: 713) Year end date: 31/12/2002 Currency: HK$ Auditors' Report: N/A Review of Interim Report by: Both Audit Committee and Auditors (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/1/2002 from 1/1/2001 to 30/6/2002 to 30/6/2001 ('000) ('000) Turnover : 330,924 313,405 Profit/(Loss) from Operations : 29,174 21,721 Finance cost : (2,770) (5,519) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : - - Profit/(Loss) after Tax & MI : 23,893 15,230 % Change over Last Period : +57% EPS/(LPS)-Basic : 3.5 cents 2.3 cents -Diluted : N/A 2.0 cents Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : 23,893 15,230 Interim Dividend per Share : 0.5 cent 0.5 cent (Specify if with other options) : N/A N/A B/C Dates for Interim Dividend : 3/10/2002 to 7/10/2002 bdi. Payable Date : 5/11/2002 B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remark: EARNINGS PER SHARE The calculations of the basic and diluted earnings per share is based on the following data: 1/1/2002 1/1/2001 to to 30/6/2002 30/6/2001 --------- --------- HK$'000 HK$'000 Earnings for the purpose of calculating basic earnings per share 23,893 15,230 ====== Interest on convertible redeemable note 1,213 --------- Earnings for the purpose of calculating diluted earnings per share 16,443 ========= Weighted average number of shares for the purpose of calculating basic earnings per share 676,417,401 672,422,407 =========== Potential dilutive shares issuable under: Convertible redeemable note 132,000,000 ------------ Weighted average number of shares for the purpose of calculating diluted earnings per share 804,422,407 =========== In calculating diluted earnings per share, the exercise of the Company's outstanding share options has not been taken into consideration as the exercise price of those options of HK$0.32 per share was higher than the average market price of the Company's shares throughout the period. |
More from Ascletis Pharma Inc.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 18
Regulatory Filings
2026
Mar 17
